104 related articles for article (PubMed ID: 18067828)
21. [Gene expression profiling in nasopharyngeal carcinoma determined by high density cDNA microarray].
Zhang LJ; Fang Y; Ma YH; Yan J; Zhang XS; Huang BJ; Zeng YX
Ai Zheng; 2002 Jun; 21(6):588-92. PubMed ID: 12452055
[TBL] [Abstract][Full Text] [Related]
22. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma.
Lung HL; Bangarusamy DK; Xie D; Cheung AK; Cheng Y; Kumaran MK; Miller L; Liu ET; Guan XY; Sham JS; Fang Y; Li L; Wang N; Protopopov AI; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Oncogene; 2005 Sep; 24(43):6525-32. PubMed ID: 16007174
[TBL] [Abstract][Full Text] [Related]
23. [Identification of differentially expressed genes in primary cultured nasopharyngeal carcinoma cells by cDNA microarray].
Li RP; Shao JY; Deng L; Zeng MS; Song LB; Li MZ; Wu QL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1156-60. PubMed ID: 17715014
[TBL] [Abstract][Full Text] [Related]
24. [cDNA expression array in the differential expression profiles of p53 regulated genes in nasopharyngeal carcinoma and the human normal nasopharynx].
Li H; Han W; Zhang L
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):448-50. PubMed ID: 11859706
[TBL] [Abstract][Full Text] [Related]
25. [Gene expression profiles in different tissues of human nasopharyngeal carcinoma].
Han HX; Yao LS; Wang S; Han WN; Yao KT
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1126-9. PubMed ID: 15485782
[TBL] [Abstract][Full Text] [Related]
26. [Expression of cytochrome P450 enzymes in human nasopharyngeal carcinoma and non-cancerous nasopharynx tissue].
Jiang JH; Jia WH; Qin HD; Liang H; Pan ZG; Zeng YX
Ai Zheng; 2004 Jun; 23(6):672-7. PubMed ID: 15191668
[TBL] [Abstract][Full Text] [Related]
27. Mutation and abnormal expression of the fragile histidine triad gene in nasopharyngeal carcinoma.
Deng YF; Tian F; Lu YD; Chen ZC; Xie DH; Yang XM; Shao XY
Laryngoscope; 2001 Sep; 111(9):1589-92. PubMed ID: 11568610
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.
Wu D; Ding Y; Wang S; Zhang Q; Liu L
J Pathol; 2008 Oct; 216(2):167-75. PubMed ID: 18680137
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma.
Zhou L; Feng X; Shan W; Zhou W; Liu W; Wang L; Zhu B; Yi H; Yao K; Ren C
Oncology; 2007; 72(5-6):357-63. PubMed ID: 18187958
[TBL] [Abstract][Full Text] [Related]
30. MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment.
Tse KP; Tsang NM; Chen KD; Li HP; Liang Y; Hsueh C; Chang KP; Yu JS; Hao SP; Hsieh LL; Chang YS
Clin Cancer Res; 2007 Nov; 13(21):6320-6. PubMed ID: 17975143
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of Epstein-Barr virus A73 gene polymorphisms to susceptibility to nasopharyngeal carcinoma].
Zhang LL; Li DJ; Li ZH; Zhang XS; Zhang RH; Yu XJ; Chen LZ; Feng QS; Zeng YX; Jia WH
Ai Zheng; 2007 Oct; 26(10):1047-51. PubMed ID: 17927871
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of gp130 in nasopharyngeal carcinoma.
Lin YS; Lin LC; Huang MH; Huang AJ; Huang YT
Am J Rhinol Allergy; 2009; 23(1):28-32. PubMed ID: 19379608
[TBL] [Abstract][Full Text] [Related]
33. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
[TBL] [Abstract][Full Text] [Related]
34. [Changes of superoxide dismutase (SOD) and metallothionien (MT) before, during, and after radiotherapy for nasopharyngeal carcinoma and their significance].
Su Y; Xia YF; Yang HL; He JH; Wu QL; Zheng Q; Hou JH
Ai Zheng; 2003 Jun; 22(6):629-33. PubMed ID: 12948415
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of splicing variants in NASG 3'UTR, down-regulated in nasopharyngeal carcinoma, and its expression in multiple cancer tissues].
Zhang BC; Zhu SG; Xiang JJ; Zhou M; Nie XM; Xiao BY; Li XL; Li GY
Ai Zheng; 2003 May; 22(5):477-80. PubMed ID: 12753706
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma.
Gao LB; Liang WB; Xue H; Rao L; Pan XM; Lv ML; Bai P; Fang WL; Liu J; Liao M; Zhang L
Clin Chim Acta; 2009 Nov; 409(1-2):132-5. PubMed ID: 19758567
[TBL] [Abstract][Full Text] [Related]
38. [The role of cytokeratin 13 gene in human nasopharyngeal carcinoma].
Qiu Y; Tian Y; Xiao J
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):444-6. PubMed ID: 11776622
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of characteristics of gene expression in pericancerous stromal cells of nasopharyngeal carcinoma by cDNA array].
Li H; Han WN; Feng XL; Zhou W; Yao KT
Ai Zheng; 2003 Mar; 22(3):235-8. PubMed ID: 12654176
[TBL] [Abstract][Full Text] [Related]
40. Reduced plasma RNA integrity in nasopharyngeal carcinoma patients.
Wong BC; Chan KC; Chan AT; Leung SF; Chan LY; Chow KC; Lo YM
Clin Cancer Res; 2006 Apr; 12(8):2512-6. PubMed ID: 16638860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
